NCT06305494

Brief Summary

Women often face common cancers like ovarian, uterine, and cervical cancers. Improvements in cancer detection and treatment mean more women survive. However, survivors can encounter challenges like ongoing pain, treatment complications, and fertility issues. Treating these cancers often involves surgeries that might include removing ovaries or using pelvic radiation. This can trigger menopause in younger women, causing problems like vaginal dryness, itching, and urinary issues. Women who've gone through menopause often deal with these symptoms, affecting their daily lives, confidence, and intimate relationships. Though treatments are available, lack of awareness, embarrassment, and not discussing these issues with doctors can make managing them difficult. The main treatment for these symptoms is using vaginal estrogen, but it might not be suitable for some cancer survivors. Non-hormonal options like lubricants and moisturizers are alternatives. This study in Thailand aiming to explore how common these issues are among gynecological cancer survivors, their feelings about it, and how it affects their quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
425

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

March 14, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

March 3, 2024

Last Update Submit

April 24, 2024

Conditions

Keywords

Genitourinary syndrome of menopauseGynecologic cancer

Outcome Measures

Primary Outcomes (1)

  • Prevalence of genitourinary syndrome of menopause

    Prevalence of genitourinary syndrome of menopause among gynecologic cancer survivor (percent)

    Baseline

Secondary Outcomes (3)

  • Severity of genitourinary syndrome of menopause

    Baseline

  • Quality of life of gynecologic cancer survivor

    Baseline

  • Attitude toward genitourinary syndrome of menopause in gynecologic cancer survivor

    Baseline

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Gynecologic cancer survivors, age more than 18 years old that came to the Gynecology Clinic at Khon Kaen University Hospital for routine cancer surveillance.

You may qualify if:

  • Participant with gynecologic cancer (cancer of ovary, fallopian tube, uterus, cervix, vagina, and vulva.)
  • Time passed more than 6 months since last cancer treatment.

You may not qualify if:

  • Participant not entering menopause after cancer treatment.
  • Participant with cancer progression.
  • Participant currently suffer from severe pain, fatigue, or discomfort.
  • Participant deny to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Khon Kaen University

Khon Kaen, 40002, Thailand

RECRUITING

MeSH Terms

Conditions

Atrophic VaginitisLower Urinary Tract Symptoms

Condition Hierarchy (Ancestors)

VaginitisVaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Apiwat Jongjakapun, MD

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Apiwat Jongjakapun, MD

CONTACT

Teerayut Temtanakitpaisan, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 3, 2024

First Posted

March 12, 2024

Study Start

March 14, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

April 25, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations